Patent Baristas
Besides patent law and litigation issues, Patent Baristas covers items relating to building a bioscience business, nanotechnology, technology transfer, orange book filings as well as FTC and FDA regulatory matters.
Author: Editor-in-chief barista Stephen Albainy-Jenei is the founder and owner of Patent Baristas. He is also a partner at Frost Brown Todd in Cincinnati. When not serving up patent chat over a cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields for leading research institutes, as well as biotechnology and pharmaceutical companies ranging from start-up to Fortune 500 companies.
Blawg Related Categories: Government Law • Intellectual Property Law • Patent Law • Science & Technology Law • Trials & Litigation • Partner • Blawg 100
Recent Posts from Patent Baristas
-
ACLU/PUBPAT Gene Patent Challenge Moves Ahead
A federal district court said that the ACLU et al. suit challenging the patentability of gene patents can go forward. The American Civil Liberties Union (ACLU), the Public Patent Foundation (PUBPAT), and a whole host…
-
IPCC: Behind The Scenes Look At Patent Cases
At the BIO’s IPCC Conference today, attendees were treated to a look at pending cases that concern biotech. John Dragseth, a Partner at Fish & Richardson, gave an overview of the Mayo v. Prometheus case…
-
Patent Reexamination in the Life Sciences
At today’s session of BIO’s IPCC Conference, Gregory Morse of the Central Reexamination Unit of the US Patent and Trademark Office gave a presentation of the process for handling re-exams. Comparing ex parte and inter…
-
BIO IPCC Meeting Starts Off With Some Advice From Circuit Judge Michel
BIO’s Intellectual Property Counsel Committee is holding its Fall Conference and Committee Meeting got off to a great start today. The meeting started off with an IP Counsels Committee Business Retreat – a day-long meeting…
-
Senate Judiciary Committee Passes Amended Bill Banning Pay-For-Delay Settlements
The U.S. Senate Judiciary Committee voted to pass a compromise version of the bill by members Herb Kohl (D-WI) and Chuck Grassley (R-IA) banning pay-for-delay settlements that keep generic drugs off the market. The “Preserve…